Latest updates for Ardx

Fresh curated links around ARDX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call Transcript
  • Ardelyx President and CEO Sells 41,000 Shares for $243,000
  • Accelerant (ARX) Q1 2026 Earnings Transcript

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /4 weeks ago

Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call Transcript

Read source
fool.com /1 month ago

Ardelyx President and CEO Sells 41,000 Shares for $243,000

This biotech innovator in gastrointestinal and kidney therapies reported a notable insider sale amid routine portfolio adjustments.

Read source
fool.com /2 weeks ago

Accelerant (ARX) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Jeffrey RadkeChief Financial Officer — Linda HuberHea...

Read source
fool.com /2 weeks ago

Accelerant (ARX) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Jeffrey RadkeChief Financial Officer — Linda HuberHea...

Read source
cafepharma.com /4 hours ago

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source
seekingalpha.com /3 weeks ago

Arcutis Biotherapeutics, Inc. (ARQT) Q1 2026 Earnings Call Transcript

Read source
investing.com /2 weeks ago

Arvinas stock gains after Rigel deal for VEPPANU rights

Read source
seekingalpha.com /3 weeks ago

Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers

Read source
cafepharma.com /1 month ago

Axonics

Axonics Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...

Read source
seekingalpha.com /1 week ago

argenx: The FcRn Franchise Is Becoming An Autoimmune Operating System

Read source
fiercebiotech.com /1 month ago

Akari locks arms with WuXi XDC to develop and manufacture novel ADC treatment

Oncology biotech Akari Therapeutics has announced a partnership with WuXi XDC, an antibody-drug conjugate (ADC) development and manufacturing company, to accelerate Akari’s drug de...

Read source
cafepharma.com /3 weeks ago

Axonics

Axonics Anonymous (not verified) Sat, 05/09/2026 - 08:22 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...

Read source
pharmexec.com /2 weeks ago

<![CDATA[FDA Places Full Clinical Hold on Aardvark Therapeutics’ ARD-101]]>

Read source
finance.yahoo.com /2 weeks ago

Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib

Read source
fool.com /2 weeks ago

Acurx (ACXP) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATETuesday, May 12, 2026 at 8 a.m. ETCALL PARTICIPANTSPresident & Chief Executive Officer — David P. LuciChief Financial Officer — Robert J. Sh...

Read source
seekingalpha.com /3 weeks ago

Accuray Incorporated 2026 Q3 - Results - Earnings Call Presentation

Read source
fool.com /2 weeks ago

Acurx (ACXP) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATETuesday, May 12, 2026 at 8 a.m. ETCALL PARTICIPANTSPresident & Chief Executive Officer — David P. LuciChief Financial Officer — Robert J. Sh...

Read source
seekingalpha.com /1 week ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

Read source
seekingalpha.com /2 weeks ago

Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program

Read source
seekingalpha.com /4 days ago

Applied Aerospace & Defense seeks $3.59 billion valuation in IPO

Read source
seekingalpha.com /1 week ago

Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia Transcript

Read source
seekingalpha.com /3 weeks ago

ARN Media Limited (ARNMF) Shareholder/Analyst Call Transcript

Read source
finance.yahoo.com /2 weeks ago

CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Ardx

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source